184 related articles for article (PubMed ID: 29263225)
21. Clinical manifestations of patients with CASPR2 antibodies.
Sunwoo JS; Lee ST; Byun JI; Moon J; Shin JW; Jeong DE; Lee GH; Jeong SH; Shin YW; Jung KH; Lee DY; Jeon D; Jung KY; Kim M; Lee SK; Chu K
J Neuroimmunol; 2015 Apr; 281():17-22. PubMed ID: 25867463
[TBL] [Abstract][Full Text] [Related]
22. [Neuroimmunological diseases associated with VGKC complex antibodies].
Watanabe O
Nihon Rinsho; 2013 May; 71(5):915-20. PubMed ID: 23777104
[TBL] [Abstract][Full Text] [Related]
23. Morvan syndrome with Caspr2 antibodies. Clinical and autopsy report.
Sundal C; Vedeler C; Miletic H; Andersen O
J Neurol Sci; 2017 Jan; 372():453-455. PubMed ID: 27802867
[No Abstract] [Full Text] [Related]
24. Cramp-fasciculation syndrome in patients with and without neural autoantibodies.
Liewluck T; Klein CJ; Jones LK
Muscle Nerve; 2014 Mar; 49(3):351-6. PubMed ID: 23836298
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal CSF Findings in Autoimmune Encephalitis-A Monocentric Cohort Study.
Zrzavy T; Höftberger R; Wimmer I; Berger T; Rommer P; Macher S
Front Immunol; 2021; 12():646940. PubMed ID: 33828556
[TBL] [Abstract][Full Text] [Related]
26. Morvan syndrome as a paraneoplastic disorder of thymoma with anti-CASPR2 antibodies.
Vale TC; Pedroso JL; Dutra LA; Azevedo L; Filho LH; Prado LB; Hoftberger R; Prado GF; Barsottini OG
Lancet; 2017 Apr; 389(10076):1367-1368. PubMed ID: 28379152
[No Abstract] [Full Text] [Related]
27. Caspr2 antibodies in patients with thymomas.
Vincent A; Irani SR
J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S277-80. PubMed ID: 20859119
[TBL] [Abstract][Full Text] [Related]
28. CASPR2 autoimmunity in children expanding to mild encephalopathy with hypertension.
Syrbe S; Stettner GM; Bally J; Borggraefe I; Bien CI; Ferfoglia RI; Huppke P; Kern J; Polster T; Probst-Müller E; Schmid S; Steinfeld R; Strozzi S; Weichselbaum A; Weitz M; Ziegler A; Wandinger KP; Leypoldt F; Bien CG
Neurology; 2020 Jun; 94(22):e2290-e2301. PubMed ID: 32424051
[TBL] [Abstract][Full Text] [Related]
29. [Paraneoplastic neurological autoimmune diseases].
Voltz R
Dtsch Med Wochenschr; 2004 Aug; 129(33):1743-6. PubMed ID: 15295685
[No Abstract] [Full Text] [Related]
30. Dramatic improvement after rituximab in a patient with paraneoplastic treatment-refractory Morvan syndrome associated with anti-CASPR2 antibodies.
Ong E; Viaccoz A; Ducray F; Pérol M; Cavillon G; Rogemond V; Honnorat J; Petiot P
Eur J Neurol; 2013 Jul; 20(7):e96-7. PubMed ID: 23750840
[No Abstract] [Full Text] [Related]
31. Characterization of a Subtype of Autoimmune Encephalitis With Anti-Contactin-Associated Protein-like 2 Antibodies in the Cerebrospinal Fluid, Prominent Limbic Symptoms, and Seizures.
Joubert B; Saint-Martin M; Noraz N; Picard G; Rogemond V; Ducray F; Desestret V; Psimaras D; Delattre JY; Antoine JC; Honnorat J
JAMA Neurol; 2016 Sep; 73(9):1115-24. PubMed ID: 27428927
[TBL] [Abstract][Full Text] [Related]
32. Neuronal central nervous system syndromes probably mediated by autoantibodies.
Chefdeville A; Honnorat J; Hampe CS; Desestret V
Eur J Neurosci; 2016 Jun; 43(12):1535-52. PubMed ID: 26918657
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness of immunotherapy in a CASPR2 and LGI1 antibody-positive elderly patient with Isaacs' syndrome: a case study.
Ye Z; Jin Y; Xu H; Qiao X; Yu H; Xu S; Jin Y
Acta Neurol Belg; 2021 Apr; 121(2):577-579. PubMed ID: 32686024
[No Abstract] [Full Text] [Related]
34. [Clinical Characteristics of Autoimmune Disease with Dual Seropositive Antibodies of Leucine-rich Glioma Inactivated 1 and Contactin-associated Protein 2].
Dong LL; Guan HZ; Huang Y; Hao HL; Niu JW; Liu Q; Lu Q; Xu D; Zhang JY; Zhou LX; Jin LR; Ren HT; Zhu YC; Peng B; Cui LY; Zhou XQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Jun; 41(3):344-350. PubMed ID: 31282328
[TBL] [Abstract][Full Text] [Related]
35. [Immune-mediated encephalomyelitis].
Wildemann B; Bien CG
Nervenarzt; 2013 Apr; 84(4):435. PubMed ID: 23525588
[No Abstract] [Full Text] [Related]
36. Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome.
Bien CG; Mirzadjanova Z; Baumgartner C; Onugoren MD; Grunwald T; Holtkamp M; Isenmann S; Kermer P; Melzer N; Naumann M; Riepe M; Schäbitz WR; von Oertzen TJ; von Podewils F; Rauschka H; May TW
Eur J Neurol; 2017 Jan; 24(1):175-186. PubMed ID: 27786401
[TBL] [Abstract][Full Text] [Related]
37. [Autoimmune pathology in neuropaediatrics: what aspects have really undergone a change].
Cantarin-Extremera V
Rev Neurol; 2017 May; 64(s03):S39-S44. PubMed ID: 28524218
[TBL] [Abstract][Full Text] [Related]
38. Persistent microglial activation and synaptic loss with behavioral abnormalities in mouse offspring exposed to CASPR2-antibodies in utero.
Coutinho E; Menassa DA; Jacobson L; West SJ; Domingos J; Moloney TC; Lang B; Harrison PJ; Bennett DLH; Bannerman D; Vincent A
Acta Neuropathol; 2017 Oct; 134(4):567-583. PubMed ID: 28755208
[TBL] [Abstract][Full Text] [Related]
39. Encephalopathy with upper body hypertonia and myoclonus in patient with systemic lupus erythematosus and anti-CASPR2.
Castro A; Romeu JC; Geraldes R; Pereira da Silva JA
Lupus; 2017 Jan; 26(1):84-87. PubMed ID: 27432809
[TBL] [Abstract][Full Text] [Related]
40. Guillain-Barré syndrome associated with CASPR2 antibodies: two paediatric cases.
Rosch RE; Bamford A; Hacohen Y; Wraige E; Vincent A; Mewasingh L; Lim M
J Peripher Nerv Syst; 2014 Sep; 19(3):246-9. PubMed ID: 25413786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
